Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StrateGlio: Treatment Intensification With Temozolomide in Adults With a Glioblastoma
NCT03663725Phase 3Active, not recruiting
- Sponsor
- Centre Oscar Lambret
- Start
- Mar 2019
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide in glioblastoma (GBM), sponsored by Centre Oscar Lambret. Started Mar 2019; status: active, not recruiting.
02
Drugs
temozolomide
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT03663725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03663725.